Once a mother is infected or vaccinated, her breast milk contains high levels of Covid antibodies

There are now several studies looking at breast milk antibody responses in women.

Catherine Thornton, The Conversation

 & 

April Rees, The Conversation

· 2 hours ago

Many say Covid-19 will transition ‘from epidemic to endemic’. But what does this mean?

In an endemic future, we will need to learn what levels of disease and death to expect.

Murad Banaji

· 16 hours ago

Yes, Ivermectin is a Nobel Prize-winning wonder drug. No, it is not meant to save lives from Covid

Many organisations with dubious intentions have continued to promote the unsubstantiated use of the medicine against the pandemic.

Jeffrey R Aeschlimann, The Conversation

· Oct 16, 2021 · 09:30 pm

The world is warming up to the idea of booster shots. Shouldn’t India consider it too?

With global data indicating vaccines’ waning immunity, vulnerable populations may benefit from a fresh infusion of antibody-producing sera.

Manavi Kapur, qz.com

· Oct 16, 2021 · 01:30 pm

First, India lacked oxygen plants in hospitals. Now, it lacks technicians to operate them

India accelerated the setting up of PSA oxygen plants after the second wave of Covid-19. But it did not factor in the lack of infrastructure in rural hospitals.

Tabassum Barnagarwala

· Oct 16, 2021 · 06:30 am

In India, a deadly oxygen crisis created new business opportunities. But now the bubble has burst

The government encouraged private investments in PSA oxygen plants. But as Covid-19 cases fall, there are no takers for the oxygen produced in these units.

Tabassum Barnagarwala

· Oct 15, 2021 · 06:30 am

Six months after deadly Covid-19 second wave, what has India done to avert a future oxygen crisis?

The Centre has avoided acknowledging the deaths caused by an oxygen shortfall this summer. But it has quietly modified the way it assesses India’s oxygen needs.

Tabassum Barnagarwala

· Oct 14, 2021 · 06:30 am

The rise and fall of convalescent plasma therapy as a Covid-19 treatment

While initial studies and some clinical trials were promising, the treatment offered no benefit to the patients who received it.

Andrew McLachlan, The Conversation

 & 

Sophie Stocker, The Conversation

· Oct 10, 2021 · 11:30 pm

Investigation: India delayed crucial syringe orders – now the world will pay a price

Letters show manufacturers repeatedly asked the government for clarity on India’s requirements for Covid-19 vaccinations. But the government did not respond.

Tabassum Barnagarwala

· Oct 10, 2021 · 06:30 am

A new oral antiviral drug for Covid-19 is moving into the final stages of testing in humans

In an initial trial, molnupiravir had successfully reduced the ability of SARS-CoV-2 to replicate.

Filipa Henderson Sousa, The Conversation

 & 

Peter Barlow, The Conversation

· Oct 07, 2021 · 07:30 pm

What the world can learn from Bhutan’s remarkable Covid-19 vaccine rollout success

By the end of July, the country had fully vaccinated 90% of its adults.

Sarah Schiffling, The Conversation

 & 

Chris Phelan, The Conversation

· Oct 05, 2021 · 11:30 pm

Lessons from Covid-19: How the pandemic has changed the dynamics of government-NGO collaborations

The coronavirus crisis has established that charitable organisations play a critical role in helping authorities deliver aid to vulnerable populations.

Pritha Venkatachalam

, 

Niloufer Memon

 & 

Umang Manchanda

· Oct 05, 2021 · 06:30 am